Recent Updates on microRNA as Potential Biomarkers for Diagnosis of Gestational Diabetes Mellitus

Authors

  • Kazi Mahmuda Akter Center for Biomedical Research and Training (CBRT), Dhaka, Bangladesh
  • Badar Uddin Umar Center for Biomedical Research and Training (CBRT), Dhaka, Bangladesh
  • SM Niazur Rahman Center for Biomedical Research and Training (CBRT), Dhaka, Bangladesh

DOI:

https://doi.org/10.3329/jom.v23i2.60632

Keywords:

microRNA, diabetes, pregnancy, prenatal testing

Abstract

Background/Aims: Screening for gestational diabetes mellitus (GDM) are currently done at 24 - 28 weeks of conception, missing out on the most vulnerable period of organogenesis and thus preventing clinicians from starting treatments until the late second or third trimester. MicroRNAs (miR) are small non-coding RNA molecules that could aid in detecting or predicting GDM through establishing a novel non-invasive prenatal testing (NIPT) tool. The objective of this study was to summarize the most recent updates on plasma microRNAs as GDM diagnostic biomarkers.

Methods: Between April and June 2021, a PubMed literature search was undertaken to review recent articles on human plasma miR associated with GDM. Animal studies and papers that are written in languages other than English were excluded. Only plasma miRNAs were used to avoid coagulation biases.

Results: A total of 31 miRNAs were found significantly upregulated in the plasma samples of patients with GDM. It was found mainly during the 2nd or 3rd trimester except for miR-223 and miR-23a that were upregulated at 9 – 11 weeks of gestation.

Conclusion: Though extensive prospective cohort studies are required, miR-223 and miR-23a should be considered the most promising to develop a successful NIPT tool because they were found to be upregulated earliest, during the first trimester.

J MEDICINE 2022; 23: 146-150

Downloads

Download data is not yet available.
Abstract
11
PDF
20

Downloads

Published

2022-07-24

How to Cite

Akter, K. M. ., Umar, B. U., & Rahman, S. N. . (2022). Recent Updates on microRNA as Potential Biomarkers for Diagnosis of Gestational Diabetes Mellitus. Journal of Medicine, 23(2), 146–150. https://doi.org/10.3329/jom.v23i2.60632

Issue

Vol. 23 No. 2 (2022)

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).